advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (6)
Showing records 1 to 6
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation21504 Tafluprost, a new potent prostanoid receptor agonist: A dose-response study on pharmacodynamics and tolerability in healthy volunteers
Sutton A; Gouws P; Ropo A
International Journal of Clinical Pharmacology and Therapeutics 2008; 46: 400-406
21655 Ocular novel drug delivery: Impacts of membranes and barriers
Barar J; Javadzadeh AR; Omidi Y
Expert Opinion on Drug Delivery 2008; 5: 567-581
21571 Scope and limitations of the co-drug approach to topical drug delivery
Lau WM; White AW; Gallagher SJ; Donaldson M; McNaughton G; Heard CM
Current Pharmaceutical Design 2008; 14: 794-802
21883 Prevalence of ocular surface disease in glaucoma patients
Leung EW; Medeiros FA; Weinreb RN
Journal of Glaucoma 2008; 17: 350-355
21596 A refillable microfabricated drug delivery device for treatment of ocular diseases
Lo R; Li P-Y; Saati S; Agrawal R; Humayun MS; Meng E
Lab on a Chip - Miniaturisation for Chemistry and Biology 2008; 8: 1027-1030
21498 Ocular pharmacokinetic/pharmacodynamic modeling for multiple anti-glaucoma drugs
Sakanaka K; Kawazu K; Tomonari M; Kitahara T; Nakashima M; Nishida K; Nakamura J; Sasaki H; Higuchi S
Biological & Pharmaceutical Bulletin 2008; 31: 1590-1595
